Evaluation of Opt-Out Rapid HIV Testing in the Emergency Department
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00742898 |
Recruitment Status
:
Completed
First Posted
: August 28, 2008
Last Update Posted
: September 15, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections | Other: Non-targeted opt-out rapid HIV screening | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 120000 participants |
Allocation: | Non-Randomized |
Intervention Model: | Factorial Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | Non-targeted Opt-out Rapid HIV Screening in the Emergency Department: a Controlled Clinical Trial |
Study Start Date : | April 2007 |
Actual Primary Completion Date : | April 2009 |
Actual Study Completion Date : | April 2009 |

Arm | Intervention/treatment |
---|---|
Experimental: 1
Non-targeted opt-out rapid HIV screening fully integrated into an urban, inner-city ED.
|
Other: Non-targeted opt-out rapid HIV screening
Experimental Arm: Integrated non-targeted opt-out rapid HIV screening Active Comparator Arm: Integrated diagnostic rapid HIV testing
|
Active Comparator: 2
Diagnostic rapid HIV testing fully integrated into an urban, inner-city ED.
|
Other: Non-targeted opt-out rapid HIV screening
Experimental Arm: Integrated non-targeted opt-out rapid HIV screening Active Comparator Arm: Integrated diagnostic rapid HIV testing
|
- HIV seropositivity [ Time Frame: Immediate ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 16 Years and older (Child, Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 16 years or older
- Emergency department patients
Exclusion Criteria:
- <16 years
- Unable to provide consent (e.g., intoxicated, altered mental status)
- Critical illness
- Prisoners or detainees
- Already known to be infected with HIV
- Victims of sexual assault
- Occupational exposures

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00742898
United States, Colorado | |
Denver Health Medical Center | |
Denver, Colorado, United States, 80204 |
Principal Investigator: | Jason S. Haukoos, MD, MSc | Denver Health Medical Center | |
Study Director: | Emily Hopkins, MSPH | Denver Health Medical Center |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Jason S. Haukoos, MD, MSc / Director of Emergency Medicine Research, Denver Health Medical Center |
ClinicalTrials.gov Identifier: | NCT00742898 History of Changes |
Other Study ID Numbers: |
06-0820 U18PS000314 ( U.S. NIH Grant/Contract ) |
First Posted: | August 28, 2008 Key Record Dates |
Last Update Posted: | September 15, 2009 |
Last Verified: | September 2009 |
Keywords provided by Denver Health and Hospital Authority:
Quasi-experimental design Non-targeted opt-out rapid HIV screening Diagnostic rapid HIV testing Emergency department Effectiveness |
Efficiency Health services research Program evaluation Effectiveness and efficiency of non-targeted rapid HIV screening in the ED |
Additional relevant MeSH terms:
HIV Infections Emergencies Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Disease Attributes Pathologic Processes |